Clinical trial
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
NCT00230503 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00230503 |
|---|---|
| Title | Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B |
| Official title | Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | pradefovir mesylate, adefovir dipivoxyl |
| Enrollment | 220 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 30, 2005 |
| Last update posted | Jun 22, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: